GPP
ALT icon

Great Point Partners’s Altimmune ALT Stock Holding History

Great Point Partners’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.29M Buy
+1,741,232
New +$5.2M 1% 29

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Great Point Partners's ALT Position: Q2 2026 in Review

Great Point Partners opened a new position in Altimmune (ALT) in Q2 2026: 1,741,232 shares worth $5.29M. The stake represents 1% of the portfolio and ranks #29 among its holdings.

210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Great Point Partners held 1,741,232 shares of Altimmune worth $5.29M as of Q2 2026.
  • Altimmune was a new Great Point Partners position in Q2 2026.
  • Altimmune made up 1% of Great Point Partners's portfolio in Q2 2026, its #29 holding.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Great Point Partners's 13F filing for Q2 2026, filed 14 Aug 2026.